Published August 25, 2020
| Version v1
Patent
Open
Beta-catenin inhibitors in cancer immunotherapy
Contributors
Patent applicant:
Description
Provided herein are compositions and methods for the treatment of cancer by inhibition of β-catenin or a β-catenin pathway. In particular, inhibitors of β-catenin and/or the Wnt/p-catenin signaling pathway are employed prevent or reverse evasion of immune response or immunotherapy by cancers.
Files
US10753938.pdf
Files
(3.6 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:9f4a7d80f1b2165b9622f6b06e19dcb1
|
3.6 MB | Preview Download |
Additional details
Identifiers
- Patent number
- US 10753938 B2
- Patent application number
- US 201615555099 A
- Other
- oai:uchicago.tind.io:7357
Dates
- Patent filed
-
2016-03-04